Works matching IS 15268209 AND DT 2015 AND VI 15 AND IP 3
Results: 10
Clinical Implications of Growth Pattern and Extension of Tumor-Associated Intraductal Carcinoma of the Breast.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 227, doi. 10.1016/j.clbc.2014.11.008
- By:
- Publication type:
- Article
Magnetic Resonance Imaging-Guided Core Needle Breast Biopsies Resulting in High-Risk Histopathologic Findings: Upstage Frequency and Lesion Characteristics.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 234, doi. 10.1016/j.clbc.2014.12.005
- By:
- Publication type:
- Article
Socioeconomic and Racial Disparities in the Selection of Chest Wall Boost Radiation Therapy in Californian Women After Mastectomy.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 212, doi. 10.1016/j.clbc.2014.11.007
- By:
- Publication type:
- Article
Extent of Margin Involvement, Lymphovascular Invasion, and Extensive Intraductal Component Predict for Residual Disease After Wide Local Excision for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 219, doi. 10.1016/j.clbc.2014.12.004
- By:
- Publication type:
- Article
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER<sup>+</sup>, and HER2<sup>-</sup> Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 197, doi. 10.1016/j.clbc.2014.12.002
- By:
- Publication type:
- Article
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 204, doi. 10.1016/j.clbc.2014.12.007
- By:
- Publication type:
- Article
Which Is the Appropriate Adjuvant Endocrine Therapy for Premenopausal Patients With Breast Cancer?
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 169, doi. 10.1016/j.clbc.2014.12.008
- By:
- Publication type:
- Article
Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 191, doi. 10.1016/j.clbc.2014.12.003
- By:
- Publication type:
- Article
Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 181, doi. 10.1016/j.clbc.2014.12.006
- By:
- Publication type:
- Article
Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 3, p. 171, doi. 10.1016/j.clbc.2014.11.009
- By:
- Publication type:
- Article